Woman and Man
- | Country :
- Italy
- Sweden
- United Kingdom
- The 6 others...
- | organs : -
- | Specialty : -
Extract
Clinical and experimental studies suggest that bosentan could delay the progression of interstitial lung disease (ILD) associated with systemic sclerosis (SSc), a condition for which no established efficacious treatment is available. The present trial investigates a possible use of oral bosentan, which is currently approved for the treatment of symptoms of pulmonary arterial hypertension (PAH) WHO Class III and IV, to a new category of patients suffering from ILD associated with SSc.
Inclusion criteria
- Pulmonary fibrosis ,Scleroderma, Systemic